Principal Investigator

Dr Metrakos_JC_300

Peter Metrakos

Principal Investigator                                            


Research: Liver physiology, pathology and molecular signatures. Non-alcoholic fatty liver disease (NAFLD) is now the leading cause of liver disease in North America and can lead to Type II diabetes, liver cirrhosis (requiring liver transplantation), liver cancer (hepatocellular cancer, ) and increase the probability of other types of cancer spreading to the liver (liver metastasis). With the help of our human tissue bank and technologies such as proteomics and genomics, we hope to find new therapies for these diseases

Expertise: liver metastasis; liver ischemia/reperfusion injury; non-alcoholic liver disease; hepatocellullar carcinoma; neuroendocrine tumors; proteomics; tissue banking

Research Staff


Anthoula Lazaris


Ph.D., Biochemistry, McGill University (Canada)

Research: Over 26 years research experience, with a focus on translational cancer research

Expertise: Molecular and cellular biology, academic (over 16 years) and industry (10 years) experience, project management, and biobanking


Stephanie Petrillo

Manager, Liver Disease Biobank and Dr. Metrakos Laboratory

M.Sc., Experimental Health Science, INRS-Institut Armand-Frappier (Canada)

Research: Manage the Liver Disease Biobank, Oversee all immunohistochemistry and immunofluorescence methodology in the lab. Research of vascularity in colorectal cancer liver metastases and other types of liver diseases (Hepatocellular carcinoma, cholangio carcinoma, Nonalcoholic fatty liver disease and Nonalcoholic steatohepatitis)

Expertise: Biobanking (Ethics, sample procurement, processing and clinical data/annotation), Project management, SOP development, Immunohistochemistry and immunofluorescence, GCP (Good clinical practice), Histology


Jaclyn Chabot

Research Assistant

B.Sc., Honours Biochemistry, Carleton University (Canada)

Research: Research and project support mainly in the area of extracellular vesicles (EVs) and laboratory management support.

Expertise: Immunology and cell biology: tissue culture, cell based projects, genomics, microscopy; protein biochemistry; molecular biology; assay development; drug discovery and pre-clinical development; animal studies. General lab management, collaborations and management of CROs (external oversight of pre-clinical Pilot, MTD, and Efficacy studies). Acquired research expertise from the private sector, public sector, and academia.


Cristina Al Ali

Research Coordinator

B.Sc., Kinesiology, Université de Montréal (Canada)

Certifications: Socra CCRP® (Certified Clinical Research Professional from The Society of Clinical Research Associates)

Postdoctoral Fellows


Miran Madhar Rada

Postdoctoral Fellow

Postdoctoral fellow, Albany Medical College (USA)

Ph.D., Molecular Cell Biology, University of Leicester (UK)

Research: To identify the molecular mechanisms by which tumor cells interact with their environment to acquire anti-angiogenic therapy resistance in colorectal cancer liver metastases (CRCLM). Ultimately I hope to find a novel biomarker guided targeted therapy to block tumor metastases and chemoresistance

Expertise: Characterisation of novel post-translational modulators of p53 in various cancers. Inhibitor Apoptosis Proteins (IAPs) and fatty acid beta oxidation genes as the key regulators of ovarian cancer cisplatin resistance


Thomas Mayer

Postdoctoral Fellow

Ph.D., Immunology, Université de Sherbrooke (Canada)

Research: Investigate the role of neutrophils infiltrating colorectal cancer liver metastases (CRCLM) and their influence on the development of a replacement or desmoplastic growth pattern

Expertise: Signalling pathways and transcription factors regulating neutrophil functions namely cytokine production



Migmar Tsamchoe

Ph.D. Candidate

M.Sc., Genetics, University of Mysore (India)

Research: AI-powered multi-omic signature discovery for precision care of patients with Colorectal Cancer Liver Metastases (CRCLM). The goal of this project is to optimise the current cancer treatment strategy and contribute towards the personalised therapeutic approach in treating cancer

Expertise: Recombinant DNA technology, RT-PCR, gel electrophoresis, Site directed mutagenesis, cell culture techniques and transmission genetics



Ph.D. Candidate


e-mail address




Audrey Kapelanski-Lamoureux

Masters Candidate

B.Sc. Pharmacology & Therapeutics, McGill University (Canada)

Research: Anatomy & Cell Biology: To better understand the concurrent expression and epigenetic changes that occur in tumor cells that promotes mCRC disease progression

Expertise: Molecular biology including tissue processing, murine work, DNA gel extraction and quantification, western blots, PCR, qPCR, light and fluorescence microscopy


Diane Kim

Masters/Honours Candidate

B.Sc. / M.Sc Track - Integrated Program, McGill University (Canada)

Research: Identification of the immunoprofile of colorectal cancer liver metastasis and colorectal cancer

Expertise: Western blots and immunohistochemistry


George Jarrouj (Honours)